NCT03698825 - TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

January 3, 2022

Study Completion Date

December 28, 2022

Conditions

Metastatic Gastric Cancer

Interventions

DRUG

TEW-7197

TEW-7197 50mg tablets + Paclitaxel 80 mg/m2 D1, 8, 15 q 4 weeks TEW-7197 dose will be determined through this dose escalation study

Trial Locations (6)

Hallym University Medical Center, Anyang-si

Hwasun Chunnam university hospital, Hwasun

Chung-Ang University hospital, Seoul

Gangbuk Samsung Medical Center, Seoul

Gangnam Severance, Seoul

Shinchon Severance, Seoul